Literature DB >> 14981298

Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.

Tatsuya Moriyama1, Keiko Kishimoto, Kiyoko Nagai, Reiko Urade, Tadashi Ogawa, Shigeru Utsumi, Nobuyuki Maruyama, Motohiro Maebuchi.   

Abstract

The purpose of this study was to discover the effects of soybean beta-conglycinin (7S-globulin) and glycinin (11S-globulin) on serum lipid levels and metabolism in the livers of normal and genetically obese mice. Male normal (ICR) and obese (KK-Ay) mice were fed ad libitum high fat diets for two weeks, followed by a 2-week restriction of diet (2 g diet/mouse/day) containing 20% casein, soybean beta-conglycinin, or soybean glycinin, and then sacrificed immediately. Serum triglyceride (TG), glucose, and insulin levels of beta-conglycinin-fed mice were lower than in casein- and glycinin-fed mice of both strains. In order to analyze the related events to these effects, enzyme activities and relative mRNA levels of lipid metabolism-related proteins were measured. The activities of two enzymes related to fatty acid beta-oxidation were higher while that of fatty acid synthase was lower in livers of beta-conglycinin-fed mice than of casein-fed both mice. Messenger RNA levels of acyl-CoA oxidase (fatty acid beta-oxidation related enzyme) were significantly higher in livers of beta-conglycinin-fed mice than of both casein-fed mice. On the contrary, mRNA levels of SREBP-1 and 2 tended to be lowered in livers of soy protein-fed mice than of both casein-fed mice. Fecal excretion of TG was higher in beta-conglycinin-fed mice than in casein-fed mice. Our results demonstrated that the soy beta-conglycinin diet reduced serum TG levels by acceleration of beta-oxidation, suppression of fatty acid synthase and/or increased TG fecal excretion, and also diminished serum glucose and insulin levels. Some of these events might be caused at the transcriptional levels, judged from the result that relative messenger RNA levels of lipid metabolism-related proteins were altered. These results suggest that soy beta-conglycinin could be a potentially useful dietary protein source for the prevention of hypertriglyceridemia, hyperinsulinemia, and hyperglycemia, which are recognized as risk factors for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981298     DOI: 10.1271/bbb.68.352

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  41 in total

1.  Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism.

Authors:  Rita Vik; Bodil Bjørndal; Pavol Bohov; Trond Brattelid; Asbjørn Svardal; Ottar K Nygård; Jan E Nordrehaug; Jon Skorve; Rolf K Berge
Journal:  Eur J Nutr       Date:  2014-04-23       Impact factor: 5.614

2.  Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: a pilot feeding study.

Authors:  K M Beavers; M M Gordon; L Easter; D P Beavers; K G Hairston; B J Nicklas; M Z Vitolins
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

3.  Porcine hemoglobin promotes lipid excretion to feces more strongly than globin protein in rats.

Authors:  Ryota Hosomi; Ren Otsuka; Hirofumi Arai; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida; Kenji Fukunaga
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

4.  Comparison of endpoints relevant to toxicity assessments in 3 generations of CD-1 mice fed irradiated natural and purified ingredient diets with varying soy protein and isoflavone contents.

Authors:  Luísa Camacho; Sherry M Lewis; Michelle M Vanlandingham; Beth E Juliar; Greg R Olson; Ralph E Patton; Gonçalo Gamboa da Costa; Kellie Woodling; Estatira Sepehr; Matthew S Bryant; Daniel R Doerge; Mallikarjuna S Basavarajappa; Robert P Felton; K Barry Delclos
Journal:  Food Chem Toxicol       Date:  2016-05-24       Impact factor: 6.023

5.  The β-conglycinin deficiency in wild soybean is associated with the tail-to-tail inverted repeat of the α-subunit genes.

Authors:  Yasutaka Tsubokura; Makita Hajika; Hiroyuki Kanamori; Zhengjun Xia; Satoshi Watanabe; Akito Kaga; Yuichi Katayose; Masao Ishimoto; Kyuya Harada
Journal:  Plant Mol Biol       Date:  2011-12-23       Impact factor: 4.076

6.  The α' subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats.

Authors:  Cynthia Chatterjee; Jiajie Liu; Carla Wood; Christine Gagnon; Elroy R Cober; Judith A Frégeau-Reid; Stephen Gleddie; Chao-Wu Xiao
Journal:  Eur J Nutr       Date:  2017-03-21       Impact factor: 5.614

7.  Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line.

Authors:  Maria Notarnicola; Caterina Messa; Antonella Orlando; Benedetta D'Attoma; Valeria Tutino; Rosemary Rivizzigno; Maria Gabriella Caruso
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

8.  Intracerebroventricular administration of soy protein hydrolysates reduces body weight without affecting food intake in rats.

Authors:  Nerissa Vaughn; Anthony Rizzo; Dolores Doane; J Lee Beverly; Elvira Gonzalez de Mejia
Journal:  Plant Foods Hum Nutr       Date:  2007-12-23       Impact factor: 3.921

9.  Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions.

Authors:  Marguerite A Klein; Richard L Nahin; Mark J Messina; Jeanne I Rader; Lilian U Thompson; Thomas M Badger; Johanna T Dwyer; Young S Kim; Carol H Pontzer; Pamela E Starke-Reed; Connie M Weaver
Journal:  J Nutr       Date:  2010-04-14       Impact factor: 4.798

10.  Effect of corn gluten and its hydrolysate consumptions on weight reduction in rats fed a high-fat diet.

Authors:  Joohee Kim; Juyeon Park; Soyoung Hong; Mi Kyung Kim
Journal:  Nutr Res Pract       Date:  2009-09-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.